|
Name |
3-Buten-1-ol
|
Molecular Formula | C4H8O | |
IUPAC Name* |
but-3-en-1-ol
|
|
SMILES |
C=CCCO
|
|
InChI |
InChI=1S/C4H8O/c1-2-3-4-5/h2,5H,1,3-4H2
|
|
InChIKey |
ZSPTYLOMNJNZNG-UHFFFAOYSA-N
|
|
Synonyms |
3-Buten-1-ol; 627-27-0; but-3-en-1-ol; Allylcarbinol; 3-Butenyl alcohol; 1-Buten-4-ol; Vinylethyl alcohol; 3-Butene-1-OL; CH2=CHCH2CH2OH; BUTEN-(3)-O1-(L); 3-Buten-1-O1; 3DB2KRM1I9; NSC-60194; Homoallyl Alcohol; 25086-71-9; 1-Hydroxy-3-butene; NSC 60194; UNII-3DB2KRM1I9; 3-butenol; hydroxy-3-butene; 3-butene-ol; 3-buten-ol; EINECS 210-991-3; MFCD00002959; AI3-30545; 3-Buten-1-ol, 96%; CH2=CH(CH2)2OH; DTXSID2060836; 4-Hydroxybutane-1,2-diylradical; CHEBI:193941; AMY14291; BCP23015; NSC60194; ZINC1530356; AKOS000121865; AB00288; DB-000892; 3-Buten-1-ol, purum, >=98.0% (GC); B0236; CS-0008447; FT-0615263; EN300-28907; P16638; Q27257071; F0001-1684
|
|
CAS | 627-27-0 | |
PubChem CID | 69389 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 72.11 | ALogp: | 0.6 |
HBD: | 1 | HBA: | 1 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 20.2 | Aromatic Rings: | 0 |
Heavy Atoms: | 5 | QED Weighted: | 0.481 |
Caco-2 Permeability: | -4.197 | MDCK Permeability: | 0.00005340 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.813 |
30% Bioavailability (F30%): | 0.981 |
Blood-Brain-Barrier Penetration (BBB): | 0.996 | Plasma Protein Binding (PPB): | 41.46% |
Volume Distribution (VD): | 1.056 | Fu: | 76.00% |
CYP1A2-inhibitor: | 0.127 | CYP1A2-substrate: | 0.54 |
CYP2C19-inhibitor: | 0.028 | CYP2C19-substrate: | 0.667 |
CYP2C9-inhibitor: | 0.006 | CYP2C9-substrate: | 0.407 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.425 |
CYP3A4-inhibitor: | 0.013 | CYP3A4-substrate: | 0.224 |
Clearance (CL): | 8.412 | Half-life (T1/2): | 0.87 |
hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.034 |
Drug-inuced Liver Injury (DILI): | 0.014 | AMES Toxicity: | 0.038 |
Rat Oral Acute Toxicity: | 0.429 | Maximum Recommended Daily Dose: | 0.03 |
Skin Sensitization: | 0.819 | Carcinogencity: | 0.07 |
Eye Corrosion: | 0.985 | Eye Irritation: | 0.996 |
Respiratory Toxicity: | 0.472 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000639 | 0.409 | D0Z5BC | 0.225 | ||||
ENC000453 | 0.273 | D0BQ8Y | 0.208 | ||||
ENC000647 | 0.243 | D0R3QY | 0.200 | ||||
ENC000460 | 0.242 | D03MZQ | 0.200 | ||||
ENC000017 | 0.238 | D0C1QZ | 0.200 | ||||
ENC000463 | 0.238 | D0EP8X | 0.192 | ||||
ENC001165 | 0.235 | D00AMQ | 0.188 | ||||
ENC001154 | 0.229 | D09KDV | 0.167 | ||||
ENC004479 | 0.222 | D0X2IE | 0.167 | ||||
ENC000455 | 0.222 | D0C6OQ | 0.149 |